Navigation Links
Cypress Creek in National Study, Shows Survival To Hospital Discharge After Cardiac Arrest Doubles with Improved CPR and Impedance Threshold Device
Date:11/6/2007

Groundbreaking study looks at hospital discharge rates in Cypress Creek and

6 other cities

CYPRESS CREEK, Texas, Nov. 6 /PRNewswire/ -- Texas's Cypress Creek EMS has participated in a seven-city study on the impact of new CPR techniques, the results of which support the widespread use of the American Heart Association's new 2005 CPR guidelines, according to the study authors in a presentation at the AHA's Scientific Sessions on November 4 in Orlando. Lead author, Tom P. Aufderheide, MD, Professor of Emergency Medicine and Director of the Resuscitation Research Center in the Department of Emergency Medicine at the Medical College of Wisconsin in Milwaukee, presented the data showing a doubling of hospital discharge rates when the AHA's new CPR guidelines were consistently and effectively applied to 893 patients.

The EMS departments submitting data in the study tracked individuals who experienced cardiac arrest outside of the hospital all the way through hospital discharge. When subjects were treated with new CPR techniques including the use of the ResQPOD, an Impedance Threshold Device (ITD), the hospital discharge rates jumped from 7.9 percent to 15.7 percent, or double the survival rate of the control group.

Aufderheide said, "This menu of interventions for patients with cardiac arrest has resulted in one of the highest overall survival rates ever documented for this devastating medical condition. It represents a major breakthrough in the treatment of cardiac arrest, which we hope will be disseminated in other systems throughout the United States."

The seven EMS departments participating in the study used AHA-recommended new CPR including increased compressions, full chest wall recoil and use of the Impedance Threshold Device. The ResQPOD ITD is a $99 device that is the size of a small fist and manufactured by Advanced Circulatory Systems (ACSI).

The Impedance Threshold Device received a Class IIa r
'/>"/>

SOURCE Advanced Circulatory Systems
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Forest Laboratories and Cypress Bioscience to Host Webcast to Discuss Clinical Data Presentations for Milnacipran
2. International study strengthens case for daily calcium pill
3. Yakima Health Care Leader Tapped for Leadership Post at National Association
4. Virginia Tech Report Has National Importance
5. Donate Life America Dispels Myths About Organ & Tissue Donation Among Hispanics During National Hispanic Heritage Month
6. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
7. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
8. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
9. 4-Star Gen. Barry McCaffrey, Former U.S. Drug Czar, to Address National Drug Crisis, Keynote Grand Opening of New Allenwood, PA National Model Detox Center
10. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
11. LCA Hails International Investigators Studying Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... HealthDay Reporter , , TUESDAY, May 22 (HealthDay News) ... with earlier development of precancerous colon lesions recommend people ... a younger age than others. "Based on our ... screenings earlier, possibly at age 40, rather than at ... fellow at Washington University in St. Louis. However, ...
(Date:5/22/2012)... 2012) -- Up to half of all prostate cancer cells ... gene and formation of its unique protein -- but no ... Weill Cornell Medical College researchers have found that in these ... a little ball known as a chromatin, is warped in ... thousands of genes, turning them on or off to promote ...
(Date:5/22/2012)... 22 (HealthDay News) -- The number of liver transplants ... new study finds. Researchers said one reason for ... has become more commonplace, and many of those livers ... aren,t healthy enough to attempt a transplant. Another reason ... a condition known as fatty liver disease, which is ...
(Date:5/22/2012)... which extends the smoking ban to public places, has ... (from 40.3% to 35.3%) and in consumption amongst the ... of all ages and occupations. , SINC ... the Society of Prevention of Ibermutuamur (accidents and diseases ... of tobacco in the working populating during the first ...
(Date:5/22/2012)... News) -- Certain gene variants linked to prostate ... urinary tract symptoms, according to a new study. ... might protect against those symptoms, the study found. ... Medicine at Northwestern University in Chicago identified 38 ... in nearly 2,000 healthy, white men enrolled in ...
Breaking Medicine News(10 mins):Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3Health News:Scientists unravel role of fusion gene in prostate cancer 2Health News:Scientists unravel role of fusion gene in prostate cancer 3Health News:Scientists unravel role of fusion gene in prostate cancer 4Health News:U.S. Liver Transplants Declining 2Health News:5 percent of workers gave up smoking when the anti-tobacco law took effect 2Health News:Study Ties Genes to Lower Urinary Tract Symptoms, Prostate Cancer Risk 2
... ... Worldwide, LOS ANGELES, Nov. 15 ... an AIDS vaccine have,announced that their efforts have stumbled or, in the ... halted last week,when its vaccine was suspected of actually making some study ...
... Research Center ... in January, SEATTLE, ... which is given annually to a Major League,Baseball player who best exemplifies ... and off the field. Sweeney, a player for the Kansas City ...
... Marketshare Among Top 50 Pharma To Offer, ... Companies, SAN DIEGO, Nov. 15 Image ... services to streamline the drug,development and regulatory approval ... compliance solutions and services to emerging,and mid-market life ...
... 15 With health care fraud,becoming more ... private health insurance Special Investigative Units,(SIUs), state ... will gather,at the National Health Care Anti-Fraud ... in Anaheim, California, to learn,more about new ...
... Radiologists, COEUR D,ALENE, Idaho, Nov. 15 ... leading provider of services,to radiology groups across the ... its full range of services, an industry first, ... Meeting (North Building,- Hall B: 8551) in Chicago, ...
... with metastatic melanoma (MM) is not good. Therapeutic strategies ... however, most patients eventually succumb to progressive disease, in ... (DCs) fail to sustain an effective antitumor T cell ... melanoma cell lines and resected tumors by Norman Sharpless ...
Other Medicine News:Health News:AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF 2Health News:Mike Sweeney Named 2007 Hutch Award Winner 2Health News:ISI Announces Expansion of Mid-Market Life Science Compliance Solutions at DIA eCTD Conference 2Health News:ISI Announces Expansion of Mid-Market Life Science Compliance Solutions at DIA eCTD Conference 3Health News:ISI Announces Expansion of Mid-Market Life Science Compliance Solutions at DIA eCTD Conference 4Health News:NHCAA Annual Training Conference Bringing Together Law Enforcement, Health Insurers to Fight Health Care Fraud 2Health News:NHCAA Annual Training Conference Bringing Together Law Enforcement, Health Insurers to Fight Health Care Fraud 3Health News:NightHawk Radiology: One Source, One Solution 2Health News:NightHawk Radiology: One Source, One Solution 3Health News:NightHawk Radiology: One Source, One Solution 4
(Date:5/22/2012)... Medical Alarm Concepts Holding, Inc. (OTCQB: MDHI.PK), ... largest ever set of orders for the MediPendant™ personal ... the user to speak and listen directly through the ... tranche of this order resulted in revenue to the ... this same customer through the end of the year, ...
(Date:5/22/2012)... -- ThermoGenesis Corp. (NASDAQ: KOOL ), a ... and administration of cell therapies, today said that it ... Platform (AXP) used for the processing of cord blood. ... in the country later this year. "We ... blood market through our efforts in China, Malaysia and ...
(Date:5/22/2012)... Surgical Corp. / surgicalinstruments.com has developed an ... and scrub techs who perform surgical instrument ... The resource center provides detailed pictures and ... used to protect and sterilize surgical instruments, ... heads, fiber optic light cables, diamond knives, ...
Breaking Medicine Technology:Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 2Medical Alarm Begins Revenue Recognition from Largest Set of Orders -- Releases New Television Commercial 3ThermoGenesis Announces Axp Approval In Thailand 2ThermoGenesis Announces Axp Approval In Thailand 3Millennium Surgical Corp. Develops Online Sterilization Resource Center 2Are All Those Handshakes at Graduation Hazardous to Your Health 3F 82134 1Are All Those Handshakes at Graduation Hazardous to Your Health 3F 82134 2Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 1Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 2Local Partnership Addresses Lagging Scores and Interest in Science and Math Among Students 19515 3Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 1Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 2Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 3Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 4Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 5Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 6Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 7Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 8Amgen Receives CHMP Positive Opinion for XGEVA u2122 28Denosumab 29 in the European Union 17464 9
... 30 Peptimmune, Inc. a privately,held biotechnology ... Patent Number,7,381,790 (the ,790 patent) which protects ... copolymer for the treatment of autoimmune diseases., ... Ib multiple-ascending dose,double-blind, placebo-controlled randomized study in ...
... 30 Wound Care Innovations, LLC,a subsidiary of ... today an evidence based study with a NE ... wound care collagen,product, CellerateRx(R), on diabetic venous ulcers. ... Control and Prevention, diabetes now,affects nearly 24 million ...
Other Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2
Bookler Richardson Blade Set - for use with Bookler Universal Table Mounted Retractor Systems...
... word cohesive is a new term being used today ... the more liquid fill that may have been used ... not new science, this is not new technology ... to describe the sticking together nature of the gel. ...
Inquire...
Inquire...
Medicine Products: